** Shares of biotech co Ginkgo Bioworks DNA.N fall 4% to $9.9
** Co late on Tuesday forecast 2025 revenue to be $160 mln to $180 mln, lower than analyst estimates of $189 mln as per data compiled by LSEG
** DNA reported Q4 net loss of $107.5 mln, vs analyst estimates of $80.1 mln
** Co reported Q4 revenue of $44 mln, vs analyst estimates of $44.5 mln
** Stock has fallen 82.4% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。